5 December 2011 Clarity Pharmaceuticals has been awarded two Commercialisation Australia grants totalling $300,000. The “Skills and Knowledge” and “Proof of Concept” grants will help Clarity provide its PET imaging agents and services for human clinical studies, and aid in Clarity’s diagnostic development program. The funding will directly contribute to a clinical trial validating one…
November 2011 Dr Paul Donnelly has been awarded an ARC Linkage grant worth over $500,000, with Clarity Pharmaceuticals as an industry partner. Dr Donnelly is a Senior Lecturer of the School of Chemistry at the University of Melbourne and a member of the Bio21 Institute, whose vision is to “improve health and the environment through…
30 July 2012 Dalton Pharma Services, a leading provider of development and manufacturing services to pharmaceutical companies, today announced the Company has entered into a Manufacturing Services Agreement with Clarity Pharmaceuticals based in Sydney, Australia. Clarity is a specialty radiopharmaceutical company dedicated to the development of clinical tools for PET imaging and companion diagnostics. Dalton Pharma Services will…